<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="potocki-lupski" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">potocki-lupski</book-part-id>
      <title-group>
        <title>Potocki-Lupski Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Duplication 17p11.2 Syndrome, PTLS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Potocki</surname>
            <given-names>Lorraine</given-names>
          </name>
          <degrees>MD, FACMG</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>lpotocki@bcm.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Neira-Fresneda</surname>
            <given-names>Juanita</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>juanita.neira@bcm.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yuan</surname>
            <given-names>Bo</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>by2@bcm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>8</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gsd2" document-type="chapter">Pompe Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pws" document-type="chapter">Prader-Willi Syndrome</related-object>
      <abstract id="potocki-lupski.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Potocki-Lupski syndrome (PTLS) is characterized by cognitive, behavioral, and medical manifestations. Cognitively, most individuals present with global developmental delay, later meeting criteria for moderate intellectual disability. Behaviorally, issues with attention, hyperactivity, withdrawal, and anxiety may be seen. Some individuals meet criteria for autism spectrum disorder. Medically, hypotonia, oropharyngeal dysphagia leading to failure to thrive, congenital heart disease, hypoglycemia associated with growth hormone deficiency, and mildly dysmorphic facial features are observed. Medical manifestations typically lead to identification of PTLS in infancy; however, those with only behavioral and cognitive manifestations may be identified in later childhood.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of PTLS is established by detection of a heterozygous duplication at chromosome 17p11.2 that encompasses <italic toggle="yes">RAI1</italic>. A recurrent 3.7-Mb duplication accounts for approximately two thirds of 17p11.2 duplications; approximately one third are non-recurrent duplications that encompass <italic toggle="yes">RAI1</italic> and vary in size from 0.41 Mb to 19.7 Mb.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A multidisciplinary evaluation involving healthcare providers from multiple specialties varies by the age and presenting issues of each individual. Management of all manifestations of PTLS is per standard care.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine monitoring for growth deceleration, short stature, failure to thrive; periodic developmental assessment by a developmental specialist; screen for behavior problems at every visit; consultation with a psychiatrist and/or psychologist if there are behavioral concerns; follow up of congenital heart disease as per cardiac consultant.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PTLS is inherited in an autosomal dominant manner. The majority of affected individuals have a <italic toggle="yes">de novo</italic> duplication; however, parent-to-child transmission has been reported. If the 17p11.2 duplication identified in the proband is not identified in either parent, the risk for future pregnancies could be slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental somatic and or germline mosaicism for the duplication. If one of the parents has the 17p11.2 duplication, the risk to each sib of inheriting the duplication is 50%. It is not possible to reliably predict the phenotype of individuals who inherit the duplication. Prenatal testing and preimplantation genetic diagnosis using chromosomal microarray (CMA) to detect the 17q11.2 duplication found in the proband are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="potocki-lupski.Diagnosis">
        <title>Diagnosis</title>
        <sec id="potocki-lupski.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Potocki-Lupski syndrome (PTLS) <bold>should be suspected</bold> in individuals with the following [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.soleralfonso.2011.655">Soler-Alfonso et al 2011</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurodevelopmental findings:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mild-to-moderate infantile hypotonia with oropharyngeal dysphagia and failure to thrive</p>
                </list-item>
                <list-item>
                  <p>Global developmental delay; intellectual disability (typically moderate)</p>
                </list-item>
                <list-item>
                  <p>Communication disorder with verbal apraxia and abnormalities of intonation and prosody</p>
                </list-item>
                <list-item>
                  <p>Sleep-disordered breathing (most evident on sleep studies)</p>
                </list-item>
                <list-item>
                  <p>Features of autism spectrum disorder; hyperactivity</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Congenital heart disease, typically left ventricular outflow track spectrum and/or rhythm disturbances</p>
            </list-item>
            <list-item>
              <p>Growth hormone deficiency</p>
            </list-item>
            <list-item>
              <p>Mildly to nonspecific dysmorphic facial features [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>] (see <xref ref-type="fig" rid="potocki-lupski.F1">Figure 1</xref>).</p>
            </list-item>
          </list>
        </sec>
        <sec id="potocki-lupski.Establishing_the_Diagnosi">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PTLS <bold>is established</bold> by detection of a heterozygous duplication at chromosome 17p11.2 that encompasses <italic toggle="yes">RAI1</italic> [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2000.84">Potocki et al 2000</xref>]. Most individuals with PTLS are identified by chromosomal microarray performed in the context of evaluation for hypotonia, failure to thrive, developmental delay, intellectual disability, or autism spectrum disorder.</p>
          <p>For this <italic toggle="yes">GeneReview</italic>, the 17p11.2 recurrent duplication, observed in approximately two thirds of individuals with PTLS, is defined by a 3.7-Mb duplication at the proximal region of chromosome 17 spanning an approximate interval of 16,757,111-20,219,651 in the reference genome (NCBI Build hg19 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://genome.ucsc.edu/cgi-bin/hgGateway">genome.ucsc.edu/cgi-bin/hgGateway</ext-link>). Note: Non-recurrent duplications (which encompass <italic toggle="yes">RAI1</italic>) account for approximately one third of individuals with PTLS and vary in size from 0.41 Mb to 19.7 Mb (see <xref ref-type="sec" rid="potocki-lupski.Molecular_Genetic_Pathoge">Molecular Genetic Pathogenesis</xref>).</p>
          <p>ISCN nomenclature for the recurrent duplication is: arr[hg19] 17p11.2(16,757,111-20,219,651)x3. Note: Since this duplication is recurrent and mediated by segmental duplications, the unique genetic sequence that is duplicated is the same in all individuals with the syndrome; however, the reported size of the duplication may: (1) be slightly larger or smaller if adjacent segmental duplications are included in the size; and (2) vary based on the design of the microarray used to detect it (see <xref ref-type="sec" rid="potocki-lupski.Molecular_Genetic_Pathoge">Molecular Genetic Pathogenesis</xref>).</p>
          <p>Although several genes are within the 3.7-Mb recurrent duplication, only <italic toggle="yes">RAI1</italic> has been implicated as the dosage-sensitive cause of the phenotype [<xref ref-type="bibr" rid="potocki-lupski.REF.bi.2005.983">Bi 2005</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.walz.2004.367">Walz et al 2004</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.walz.2006.3035">Walz et al 2006</xref>]. (See <xref ref-type="sec" rid="potocki-lupski.Molecular_Genetics">Molecular Genetics</xref> for genes of interest in the duplicated region.)</p>
          <p><bold>The best genomic testing method</bold> is <bold>chromosomal microarray (CMA)</bold> using oligonucleotide or SNP arrays that can detect the recurrent duplication in a proband. The ability to size the duplication depends on the type of microarray used and the density of probes in the 17p11.2 region. Note: (1) This duplication is the reciprocal recombination product of the <related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith-Magenis syndrome</related-object> (SMS) deletion; therefore, this region has been represented since the inception of array CGH technology. (2) Although interphase fluorescent in situ hybridization using <italic toggle="yes">RAI1</italic> or high-resolution G-banded chromosome analysis can detect the recurrent 3.7-Mb duplication, these methods are highly dependent on cell preparation and technical skills, and thus lack sensitivity [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>].</p>
          <table-wrap id="potocki-lupski.T.genomic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Genomic Testing Used in Potocki-Lupski Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" colspan="1" headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_1">Duplication&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" colspan="1" headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_2">Test<break/>Method</th>
                  <th id="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" style="background-color:rgb(255,255,255)" rowspan="1">Test Sensitivity</th>
                </tr>
                <tr>
                  <th headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3" id="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" style="background-color:rgb(255,255,255)" rowspan="1">Proband</th>
                  <th headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3" id="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">At-Risk Family Members</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" colspan="1">Heterozygous duplication at 17p11.2&#x000a0;<sup>2</sup>:<break/>arr[hg19] 17p11.2(16,757,111-20,219,651)x3&#x000a0;<sup>3</sup><break/>[ClinGen ID: ISCA-37418]</td>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">CMA&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3 hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3 hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1">Targeted<break/>duplication<break/>analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3 hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Not<break/>applicable&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_1_3 hd_h_potocki-lupski.T.genomic_testing_used_in_1_1_2_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="potocki-lupski.TF.1.1">
                <label>1. </label>
                <p>See <xref ref-type="sec" rid="potocki-lupski.Molecular_Genetics">Molecular Genetics</xref> for details of the duplication and genes of interest in the region.</p>
              </fn>
              <fn id="potocki-lupski.TF.1.2">
                <label>2. </label>
                <p>For this <italic toggle="yes">GeneReview</italic>, the 17p11.2 recurrent duplication, observed in approximately two thirds of individuals with PTLS, is defined a 3.7-Mb duplication at the proximal region of chromosome 17 spanning an approximate interval of 16,757,111-20,219,651 in the reference genome. Non-recurrent duplications, which encompass <italic toggle="yes">RAI1</italic>, account for approximately one third of individuals with PTLS and vary in size from 0.41 Mb to 19.7 Mb.</p>
              </fn>
              <fn id="potocki-lupski.TF.1.3">
                <label>3. </label>
                <p>Standardized ISCN annotation and interpretation for genomic variants from the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicalgenome.org/about/">Clinical Genome Resource Project</ext-link> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium). Genomic coordinates represent the minimum duplication size associated with the 17p11.2 recurrent duplication as designated by ClinGen. Duplication coordinates may vary slightly based on array design used by the testing laboratory. Note that the size of the duplication as calculated from these genomic positions may differ from the expected duplication size due to the presence of segmental duplications near breakpoints. The phenotype of significantly larger or smaller duplications within this region may be clinically distinct from Potocki-Lupski syndrome (see <xref ref-type="sec" rid="potocki-lupski.Genetically_Related_Disor">Genetically Related Disorders</xref>).</p>
              </fn>
              <fn id="potocki-lupski.TF.1.4">
                <label>4. </label>
                <p>Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the 17p11.2 region.</p>
              </fn>
              <fn id="potocki-lupski.TF.1.5">
                <label>5. </label>
                <p>Targeted duplication analysis methods can include FISH, quantitative PCR (qPCR), and multiplex ligation-dependent probe amplification (MLPA) as well as other targeted quantitative methods.</p>
              </fn>
              <fn id="potocki-lupski.TF.1.6">
                <label>6. </label>
                <p>Targeted duplication analysis is not appropriate for an individual in whom the 17p11.2 recurrent duplication was not detected by CMA designed to target this region.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="potocki-lupski.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="potocki-lupski.Clinical_Description">
          <title>Clinical Description</title>
          <p>Potocki-Lupski syndrome (PTLS) is characterized by developmental delay, intellectual disability, behavioral disturbances, organ system involvement, and mildly dysmorphic facial features [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al 2010</xref>]. See <xref ref-type="fig" rid="potocki-lupski.F1">Figure 1</xref>.</p>
          <p>PTLS can manifest in infancy with hypotonia, oropharyngeal dysphagia leading to failure to thrive, congenital heart disease, and hypoglycemia associated with growth hormone deficiency. In contrast, individuals who are more mildly affected may manifest cognitive and behavioral abnormalities only, and not be diagnosed until later in childhood [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al 2010</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>].</p>
          <sec id="potocki-lupski.Neurodevelopmental">
            <title>Neurodevelopmental</title>
            <p><bold>Mild-to-moderate infantile hypotonia</bold> with oropharyngeal dysphagia is common and contributes to poor feeding and mild-to-moderate gross motor delays [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.soleralfonso.2011.655">Soler-Alfonso et al 2011</xref>]. Poor feeding or poor weight gain can be an initial presentation. Infants and children have significantly lower weight for age, weight for length, and BMI for age than the reference population [<xref ref-type="bibr" rid="potocki-lupski.REF.soleralfonso.2011.655">Soler-Alfonso et al 2011</xref>].</p>
            <p>Although gross motor delay is observed in the vast majority, most will achieve independent walking by age two years. Rarely, independent ambulation can be delayed until age four years.</p>
            <p><bold>Cognitive impairment</bold> is one of the most common characteristics of PTLS [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>]. The vast majority of individuals tested have moderate intellectual disability [<xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al 2010</xref>].</p>
            <p>Speech delay is universal. Standardized testing has revealed expressive and receptive language impairment which can include articulation difficulties and disordered intonation and prosody [<xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al 2010</xref>]. Some individuals may exhibit verbal apraxia.</p>
            <p>While there are no formal studies of articulation and language abilities in teens and adults with PTLS, verbal abilities appear to improve both with age and speech therapy. Little data regarding findings in adults are available; however, adults with a confirmed molecular genetic diagnosis who have been clinically evaluated have cognitive challenges.</p>
            <p><bold>Sleep-disordered breathing.</bold> Although sleep disturbances are not often clinically recognized and significant airway obstruction is not found on examination, abnormalities frequently evident on sleep studies include sleep-disordered breathing such as mild central and/or obstructive sleep apnea [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>]. Children with sleep apnea may present with snoring or hyperactivity. In addition, periodic limb movement disorder is commonly observed.</p>
            <p><bold>Behavioral difficulties</bold> identified by objective measures and by parental reports include attention problems, withdrawal, and high levels of hyperactivity and anxiety. Reported deficits in executive functioning include initiating and shifting activities and working memory.</p>
            <p><bold>Autism spectrum disorder (ASD)</bold> and/or autistic features (decreased eye contact, motor mannerisms or posturing, sensory hypersensitivity or preoccupation, repetitive behaviors, difficulty with transitions, lack of appropriate functional or symbolic play, and lack of joint attention) are seen in affected individuals [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al 2010</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>]. Using validated scoring systems (ADI-R and ADOS-G), <xref ref-type="bibr" rid="potocki-lupski.REF.treadwelldeering.2010.137">Treadwell-Deering et al [2010]</xref> found that approximately 60% of a small cohort of children with PTLS met criteria for ASD.</p>
          </sec>
          <sec id="potocki-lupski.Congenital_Heart_Disease">
            <title>Congenital Heart Disease</title>
            <p>Cardiovascular anomalies are reported in about 40% of individuals with PTLS [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.jefferies.2012.90">Jefferies et al 2012</xref>]. The anomalies can include atrial septal defect and ventricular septal defect, as well as anomalies within the left ventricular outflow track spectrum including bicuspid aortic valve, dilated aortic root, and hypoplastic left heart [<xref ref-type="bibr" rid="potocki-lupski.REF.sanchezvalle.2011.363">Sanchez-Valle et al 2011</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.yusupov.2011.367">Yusupov et al 2011</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.bravo.2013.394">Bravo et al 2013</xref>].</p>
            <p>A smaller percentage of individuals with PTLS have rhythm disturbances detected on ECG [<xref ref-type="bibr" rid="potocki-lupski.REF.jefferies.2012.90">Jefferies et al 2012</xref>].</p>
          </sec>
          <sec id="potocki-lupski.Growth_Hormone_Deficiency">
            <title>Growth Hormone Deficiency</title>
            <p>Five of seven individuals in the original description of PTLS had short stature; one of the five had documented growth hormone deficiency [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2000.84">Potocki et al 2000</xref>]. In a second study, one of ten individuals had short stature (but not growth hormone deficiency) [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>]. Subsequently, additional individuals with PTLS and growth hormone deficiency have been identified, including some with hypoglycemia in infancy and short stature in early childhood [Author, personal observation].</p>
          </sec>
          <sec id="potocki-lupski.Other">
            <title>Other</title>
            <p><bold>Musculoskeletal</bold> features of PTLS that can mimic those seen in connective tissue disorders include severe bilateral clubfeet [<xref ref-type="bibr" rid="potocki-lupski.REF.dhanaraj.2015.373">Dhanaraj et al 2015</xref>], joint hypermobility, kyphoscoliosis, pes planus, and long fingers and toes [<xref ref-type="bibr" rid="potocki-lupski.REF.martin.2008.211">Martin et al 2008</xref>].</p>
            <p><bold>Renal anomalies</bold> include hypoplastic, multicystic dysplastic kidneys, and hydronephrosis [<xref ref-type="bibr" rid="potocki-lupski.REF.goh.2012.1579">Goh et al 2012</xref>].</p>
            <p><bold>EEG abnormalities</bold> observed during sleep include slow occipital dominant rhythm and generalized and/or focal epileptiform abnormalities. Clinical or electroencephalographic seizures have not been reported [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>].</p>
            <p><bold>Other findings</bold> include the following [<xref ref-type="bibr" rid="potocki-lupski.REF.potocki.2007.633">Potocki et al 2007</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>Hyperopia (common, but not significant enough to require corrective lenses in childhood)</p>
              </list-item>
              <list-item>
                <p>Mild high-frequency sensorineural hearing loss</p>
              </list-item>
              <list-item>
                <p>Dental malocclusion and dental crowding</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="potocki-lupski.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is 100%; expression of phenotypic features is variable.</p>
        </sec>
        <sec id="potocki-lupski.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of PTLS is approximately one in 25,000 [<xref ref-type="bibr" rid="potocki-lupski.REF.greenberg.1991.1207">Greenberg et al 1991</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.liu.2011.580">Liu et al 2011</xref>].</p>
        </sec>
      </sec>
      <sec id="potocki-lupski.Genetically_Related_Disor">
        <title>Genetically Related Disorders</title>
        <p>Yuan-Harel-Lupski (YUHAL) syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/616652">616652</ext-link>) is caused by a contiguous gene duplication of chromosome 17p12-p11.2 that includes the genes <italic toggle="yes">PMP22</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/601097"><underline>601097</underline></ext-link>) and <italic toggle="yes">RAI1</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/607642"><underline>607642</underline></ext-link>). This syndrome is a complex neurodevelopmental disorder characterized by global developmental delay and early-onset peripheral neuropathy. The disorder comprises features of both demyelinating <related-object link-type="booklink" source-id="gene" document-id="cmt1" document-type="chapter">Charcot-Marie-Tooth disease type 1A</related-object> (CMT1A), caused by duplication of <italic toggle="yes">PMP22</italic>, and Potocki-Lupski syndrome, caused by duplication of a slightly proximal region on 17p11.2 that includes <italic toggle="yes">RAI1</italic> [<xref ref-type="bibr" rid="potocki-lupski.REF.yuan.2015.691">Yuan et al 2015</xref>].</p>
      </sec>
      <sec id="potocki-lupski.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of Potocki-Lupski syndrome (PTLS) is broad due to the wide spectrum of findings and presence of developmental delay, learning problems, and neuropsychiatric disorders &#x02013; for which the differential diagnosis is extensive. All manifestations of PTLS can also be seen individually or in combination in individuals with other genomic disorders.</p>
      </sec>
      <sec id="potocki-lupski.Management">
        <title>Management</title>
        <sec id="potocki-lupski.Evaluations_and_Referrals">
          <title>Evaluations and Referrals Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Potocki-Lupski syndrome (PTLS), the evaluations and referrals summarized in <xref ref-type="table" rid="potocki-lupski.T.recommended_evaluations">Table 2</xref> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p>
          <p>Note: Some evaluations are age dependent and may not be relevant at the time of initial diagnosis (e.g., recommendation for cognitive testing for intellectual disability during infancy).</p>
          <table-wrap id="potocki-lupski.T.recommended_evaluations" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Recommended Evaluations and Referrals Following Initial Diagnosis of Potocki-Lupski Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">System</th>
                  <th id="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Evaluation</th>
                  <th id="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Comment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Growth</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Growth assessment for evidence of failure to thrive/short stature</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>For failure to thrive or poor weight gain: feeding evaluation w/swallow function study to assess for oropharyngeal dysphagia</p></list-item><list-item><p>For short stature: bone age, IGF-1, IGFBP-3, referral to endocrinologist</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Eyes</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Ophthalmologic evaluation for strabismus &#x00026; refractive errors</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>ENT / Dental</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Audiology evaluation &#x00026; assessment for sleep apnea</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sleep study if sleep apnea is suspected</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Evaluation for dental crowding and/or malocclusion</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cardiovascular</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">ECG &#x00026; echocardiogram, incl aortic root measurements</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Gastroenterology / Nutrition</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">If failure to thrive is present</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Genitourinary</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Renal ultrasound to evaluate for structural anomalies</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Musculoskeletal</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Clinical evaluation for hypermobility, scoliosis, clubbed feet, &#x00026; pes planus</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Radiographic scoliosis survey (x-rays of spine) based on clinical suspicion</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Endocrine</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Assessment for history of hypoglycemia and/or concern for growth hormone deficiency</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Developmental / Psychiatric</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Clinical screening for developmental delay, atypical behavior, inattention, hyperactivity &#x00026; ASD</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Autism Diagnostic Observation Schedule&#x02122; (ADOS&#x02122;) to aid in diagnosis of ASD</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Medical genetics</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Consultation with a clinical geneticist and/or genetic counselor</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_evaluations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>ASD = autism spectrum disorder</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="potocki-lupski.Treatment_of_Manifestatio">
          <title>Treatment of Manifestations</title>
          <p>Depending on the age and presenting problems of the individual with PTLS, a multidisciplinary evaluation involving healthcare providers from the following specialties is often necessary: audiology, cardiology, dental, developmental pediatrics, endocrinology, feeding, gastroenterology, general pediatrics, clinical genetics, ophthalmology, orthopedics, otolaryngology, physical medicine and rehabilitation, psychiatry, sleep medicine, speech pathology, and urology.</p>
          <table-wrap id="potocki-lupski.T.treatment_of_medical_ma" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Treatment of Medical Manifestations in Individuals with PTLS</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Manifestation</th>
                  <th id="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Treatment</th>
                  <th id="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Considerations/Other</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Strabismus and/or refractive errors</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment as recommended by ophthalmologist</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Dental crowding / malocclusion</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment as recommended by dentist/orthodontist</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Evidence of sleep apnea</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment as indicated</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Assess for iron deficiency if excessive periodic limb movements are identified on sleep study.</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Poor weight gain / failure to thrive</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Feeding tube in the short term if required for nutrition &#x00026; growth</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Diet diary &#x00026; calorie counts may be requested.</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypoglycemia, short stature, evidence of growth hormone deficiency</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment(s) as recommended by endocrinologist</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cardiac anomaly, dilated aortic root/aortopathy, and/or ECG abnormality</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment as recommended by cardiologist</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Renal anomaly and/or vesicoureteral reflux</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard treatment as recommended by nephrologist/urologist</td>
                  <td headers="hd_h_potocki-lupski.T.treatment_of_medical_ma_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <sec id="potocki-lupski.Global_Developmental_Dela">
            <title>Global Developmental Delay / Intellectual Disability Educational Issues</title>
            <p>The following information represents typical management recommendations for individuals with developmental delay/intellectual disability in the United States; standard recommendations may vary from country to country.</p>
            <p><bold>Ages 0-3 years.</bold> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the United States, early intervention is a nationwide federally funded program available in all states.</p>
            <p><bold>Ages 3-5 years.</bold> In the United States, developmental preschool through the local public school district is recommended. A &#x0201c;full individual evaluation&#x0201d; (FIE) will occur before placement to determine needed services and therapies and will be subsequently integrated into an individualized education plan (IEP).</p>
            <p>
              <bold>Ages 5-21 years</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>In the United States, an IEP based on the individual&#x02019;s level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district generally until age 21.</p>
              </list-item>
              <list-item>
                <p>Discussion about transition plans including medical and financial guardianship, financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</p>
              </list-item>
            </list>
            <p><bold>All ages.</bold> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life and integration into community. Some issues to consider:</p>
            <list list-type="bullet">
              <list-item>
                <p>Private supportive therapies based on the affected individual&#x02019;s needs. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p>
              </list-item>
              <list-item>
                <p>In the United States:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Enrollment in DDA (Developmental Disabilities Administration) is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</p>
                  </list-item>
                  <list-item>
                    <p>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
          <sec id="potocki-lupski.Motor_Dysfunction">
            <title>Motor Dysfunction</title>
            <p>
              <bold>Gross motor dysfunction</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Physical therapy is recommended to maximize strength and mobility and to reduce the risk for later-onset orthopedic complications (e.g., scoliosis). Aquatic therapy and hippotherapy (therapeutic horseback riding) may also be considered.</p>
              </list-item>
              <list-item>
                <p>Consider use of durable medical equipment as needed (e.g., orthotics, adaptive strollers).</p>
                <p>Physical medicine and rehabilitation evaluations may be warranted [<xref ref-type="bibr" rid="potocki-lupski.REF.neirafresneda.2015.159">Neira-Fresneda &#x00026; Potocki 2015</xref>].</p>
              </list-item>
            </list>
            <p><bold>Fine motor dysfunction.</bold> Occupational therapy is recommended to address difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and handwriting.</p>
            <p><bold>Oral motor dysfunction.</bold> Feeding therapy, typically from an occupational or speech therapist, is recommended for affected individuals who have difficulty feeding due to poor oral motor control and/or sensory aversions, assuming the individual is safe to eat by mouth.</p>
            <p><bold>Communication issues.</bold> Consider:</p>
            <list list-type="bullet">
              <list-item>
                <p>Speech and language therapy to address receptive and expressive language deficits, articulation abnormalities, and verbal apraxia;</p>
              </list-item>
              <list-item>
                <p>Evaluation for alternative means of communication (e.g., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.asha.org/NJC/AAC/">Augmentative and Alternative Communication</ext-link>) for individuals who have expressive language difficulties.</p>
              </list-item>
            </list>
          </sec>
          <sec id="potocki-lupski.SocialBehavioral_Difficul">
            <title>Social/Behavioral Difficulties</title>
            <p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is individualized to the child&#x02019;s behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p>
            <p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavioral management strategies or providing prescription medications when necessary.</p>
          </sec>
        </sec>
        <sec id="potocki-lupski.Surveillance">
          <title>Surveillance</title>
          <table-wrap id="potocki-lupski.T.recommended_surveillanc" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Recommended Surveillance for Individuals with PTLS</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">System</th>
                  <th id="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Evaluation</th>
                  <th id="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Frequency</th>
                  <th id="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Comments</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Growth</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Monitoring for growth deceleration, short stature, failure to thrive</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">At every visit</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>For failure to thrive or poor weight gain: feeding evaluation</p></list-item><list-item><p>For short stature: consider endocrinology evaluation.</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Eyes</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Ophthalmology evaluation</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Yearly</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>ENT / Mouth</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Audiology evaluation</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Newborn hearing screen, then as indicated for speech delay</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Dental evaluation</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Every 6 months starting in early childhood</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cardiovascular</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Echocardiogram w/attention to aortic root dimension &#x00026; ECG</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Every 3 yrs, if initial evaluations were normal; otherwise, as directed by cardiologist</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Musculoskeletal</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Monitoring for development of scoliosis</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Clinical examination at every visit</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Scoliosis survey if scoliosis is clinically suspected; referral to orthopedist if indicated</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Psychiatric</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Behavioral assessment</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Screen for behavior problems at every visit; consultation w/psychiatrist and/or psychologist if behavioral atypia present</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Autism Diagnostic Interview (ADI) and Autism Diagnostic Observation Schedule (ADOS), depending on age, for those with suspected autism</td>
                </tr>
                <tr>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Miscellaneous / Other</bold>
                  </td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Developmental monitoring by a developmental specialist</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Annually, or at frequency directed by developmental specialist</td>
                  <td headers="hd_h_potocki-lupski.T.recommended_surveillanc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>A developmental pediatrician can perform a comprehensive evaluation w/attention to underlying medical factors influencing developmental abilities.</p></list-item><list-item><p>A child psychologist can assess cognitive &#x00026; behavioral issues.</p></list-item></list>
</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="potocki-lupski.Evaluation_of_Relatives_a">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="potocki-lupski.Related_Genetic_Counselin">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="potocki-lupski.Therapies_Under_Investiga">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/"><underline>ClinicalTrials.gov</underline></ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="potocki-lupski.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="potocki-lupski.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Potocki-Lupski syndrome (PTLS) is inherited in an autosomal dominant manner. The majority of affected individuals have a <italic toggle="yes">de novo</italic> duplication; however, parent-to-child transmission has been reported [<xref ref-type="bibr" rid="potocki-lupski.REF.magoulas.2014.500">Magoulas et al 2014</xref>].</p>
        </sec>
        <sec id="potocki-lupski.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of the parents by genomic testing that will detect the 17p11.2 duplication present in the proband is recommended.</p>
            </list-item>
            <list-item>
              <p>Although not described to date, there is a theoretic (though unlikely) possibility that a parent could have somatic mosaicism for the 17p11.2 duplication.</p>
            </list-item>
            <list-item>
              <p>Note: A parent who manifests only cognitive and behavioral abnormalities may not be diagnosed with PTLS until the birth of an affected child (see <xref ref-type="sec" rid="potocki-lupski.Clinical_Description">Clinical Description</xref>).</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the 17p11.2 duplication identified in the proband is not identified in either parent, the empiric recurrence risk to sibs is approximately 1% because of the theoretic possibility of parental germline mosaicism [<xref ref-type="bibr" rid="potocki-lupski.REF.campbell.2015.382">Campbell et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>If one of the parents has the 17p11.2 duplication, the risk to each sib of inheriting the duplication is 50%. It is not possible to reliably predict the phenotype of individuals who inherit the duplication.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Offspring of an individual with the 17p11.2 duplication have a 50% chance of inheriting the duplication. It is not possible to reliably predict the exact phenotype of the individual; however, the clinical features detailed in <xref ref-type="sec" rid="potocki-lupski.Clinical_Description">Clinical Description</xref> would be expected.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the genetic status of the proband&#x02019;s parents: if a parent has the 17p11.2 duplication, his or her family members may also have the duplication.</p>
        </sec>
        <sec id="potocki-lupski.Related_Genetic_Counselin">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk apparently asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of having a child with 17p11.2 duplication.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="potocki-lupski.Prenatal_Testing_and_Prei">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Pregnancies known to be at increased risk for the 17p11.2 duplication.</bold> Prenatal testing and preimplantation genetic diagnosis using chromosomal microarray (CMA) to detect the 17q11.2 duplication found in the proband may be offered when:</p>
          <list list-type="bullet">
            <list-item>
              <p>A parent has the 17p11.2 duplication;</p>
            </list-item>
            <list-item>
              <p>Neither parent has the duplication but has had a child with the 17p11.2 duplication. In this instance, the recurrence risk associated with the possibility of parental germline mosaicism or other predisposing genetic mechanisms is approximately 1%.</p>
            </list-item>
          </list>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Pregnancies not known to be at increased risk for the 17p11.2 duplication.</bold> CMA performed in a pregnancy not known to be at increased risk for PTLS may detect the duplication.</p>
          <p>Note: Regardless of whether a pregnancy is known or not known to be at increased risk for Potocki-Lupski syndrome, prenatal genetic testing results cannot reliably predict the phenotype.</p>
        </sec>
      </sec>
      <sec id="potocki-lupski.Resources">
        <title>Resources</title>
      </sec>
      <sec id="potocki-lupski.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="potocki-lupski.Molecular_Genetic_Pathoge">
          <title>Molecular Genetic Pathogenesis</title>
          <p><bold>Duplication</bold>
<bold>mechanism.</bold> The proximal short arm of chromosome 17 is enriched with low-copy repeats (LCRs, also called segmental duplications). The 3.7-Mb recurrent 17p11.2 duplication is the result of non-allelic homologous recombination (NAHR) between homologous, directly oriented LCRs flanking the recurrent duplication region [<xref ref-type="bibr" rid="potocki-lupski.REF.park.2002.729">Park et al 2002</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.stankiewicz.2010.437">Stankiewicz &#x00026; Lupski 2010</xref>].</p>
          <p>NAHR-mediated unequal crossover between other LCRs at the 17p11.2 region results in a less commonly observed ~5-Mb recurrent duplication [<xref ref-type="bibr" rid="potocki-lupski.REF.zhang.2010.462">Zhang et al 2010</xref>]. Non-recurrent duplications overlapping 17p11.2 that are associated with PTLS have also been observed. It has been proposed that replication-based mechanisms, such as fork stalling and template switching/microhomology-mediated break-induced replication (FoSTeS/MMBIR), generate rearrangements independent of LCRs [<xref ref-type="bibr" rid="potocki-lupski.REF.hastings.2009.551">Hastings et al 2009</xref>, <xref ref-type="bibr" rid="potocki-lupski.REF.zhang.2009.849">Zhang et al 2009</xref>]. Replication-based mechanisms may generate larger duplications that encompass both the PTLS critical region at 17p11.2 and the neighboring CMT1A critical region at 17p12, thereby leading to Yuan-Harel-Lupski (YUHAL) syndrome (see <xref ref-type="sec" rid="potocki-lupski.Genetically_Related_Disor">Genetically Related Disorders</xref>, OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/616652">616652</ext-link>, <xref ref-type="bibr" rid="potocki-lupski.REF.yuan.2015.691">Yuan et al [2015]</xref>).</p>
          <p>
            <bold>Genes of interest in this region</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">RAI1.</italic></bold> All PTLS-associated duplications identified to date include the gene <italic toggle="yes">RAI1</italic> on chromosome 17p [<xref ref-type="bibr" rid="potocki-lupski.REF.zhang.2010.462">Zhang et al 2010</xref>]. Although the recurrent duplication encompasses about 70 genes, the smallest region of overlap among non-recurrent duplications resulting in the PTLS phenotype is 125 kb and includes only <italic toggle="yes">RAI1</italic> [<xref ref-type="bibr" rid="potocki-lupski.REF.zhang.2010.462">Zhang et al 2010</xref>].</p>
              <p>Moreover, using a transgenic mouse model, a Dp(11)17 allele (duplication of the region on mouse chromosome 11 that is syntenic to human PTLS region) and a null <italic toggle="yes">Rai1</italic> allele in compound heterozygous configuration rescues the phenotypes observed in heterozygous Dp(11)17 mice by maintaining normal disomic <italic toggle="yes">Rai1</italic> dosage. Moreover, the phenotype observed in Dp(11)17 mice was rescued in Dp(11)17/<italic toggle="yes">Rai1</italic>(-) despite altered trisomic copy number of the other genes within the region [<xref ref-type="bibr" rid="potocki-lupski.REF.walz.2006.3035">Walz et al 2006</xref>]. This evidence suggests that duplication of <italic toggle="yes">RAI1</italic> is sufficient to cause the phenotype.</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">FLCN.</italic></bold> Folliculin, encoded by <italic toggle="yes">FLCN</italic>, is highly expressed in kidney. <italic toggle="yes">FLCN</italic> loss-of-function variants have been reported in <related-object link-type="booklink" source-id="gene" document-id="bhd" document-type="chapter">Birt-Hogg-Dub&#x000e9; syndrome</related-object>.</p>
              <p>Comparison between the duplication segments in PTLS with renal phenotype and the syntenic duplication in mouse model suggests <italic toggle="yes">FLCN</italic> as a potential contributor to the renal abnormalities [<xref ref-type="bibr" rid="potocki-lupski.REF.goh.2012.1579">Goh et al 2012</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="potocki-lupski.References">
        <title>References</title>
        <sec id="potocki-lupski.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="potocki-lupski.Literature_Cited.reflist0">
            <ref id="potocki-lupski.REF.bi.2005.983">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W.</given-names>
                  </name>
                </person-group>
                <article-title>Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <year>2005</year>
                <volume>14</volume>
                <fpage>983</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">15746153</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.bravo.2013.394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bravo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e1;mez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000c1;guar&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Le&#x000f3;n-Luis</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of Potocki-Lupski syndrome in a fetus with hypoplastic left heart and aberrant right subclavian artery.</article-title>
                <source>J Perinatol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>394</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23624966</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.campbell.2015.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankiewicz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Somatic mosaicism: implications for disease and transmission genetics.</article-title>
                <source>Trends Genet</source>
                <volume>31</volume>
                <fpage>382</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">25910407</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.dhanaraj.2015.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dhanaraj</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappas</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehman</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Potocki-Lupski syndrome in conjunction with bilateral clubfoot.</article-title>
                <source>J Pediatr Orthop B</source>
                <volume>24</volume>
                <fpage>373</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">25768679</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.goh.2012.1579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>ES-Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canales</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agatep</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dror</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shago</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goobie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sgro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendoza-Londono</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Definition of a critical genetic interval related to kidney abnormalities in the Potocki-Lupski syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>158A</volume>
                <fpage>1579</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">22639462</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.greenberg.1991.1207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guzzetta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montes de Oca-Luna</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magenis</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>ACM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(l7)(pl 1.2).</article-title>
                <source>Am J Hum Genet</source>
                <volume>49</volume>
                <fpage>1207</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">1746552</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.hastings.2009.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hastings</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ira</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mechanisms of change in gene copy number.</article-title>
                <source>Nat Rev Genet</source>
                <volume>10</volume>
                <fpage>551</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">19597530</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.jefferies.2012.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jefferies</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignatelli</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins-Furman</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Cardiovascular findings in duplication 17p11.2 syndrome.</article-title>
                <source>Genet Med</source>
                <volume>14</volume>
                <fpage>90</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22237436</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.liu.2011.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacaria</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Withers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hastings</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Frequency of nonallelic homologous recombination is correlated with length of homology: evidence that ectopic synapsis precedes ectopic crossing-over.</article-title>
                <source>Am J Hum Genet</source>
                <volume>89</volume>
                <fpage>580</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21981782</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.magoulas.2014.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magoulas</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelowani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soler-Alfonso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivuva</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Inherited dup(17)(p11.2p11.2): expanding the phenotype of the Potocki-Lupski syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>164A</volume>
                <fpage>500</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24311450</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.martin.2008.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>SJL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Potocki-Lupski syndrome mimicking a connective tissue disorder.</article-title>
                <source>Clin Dysmorph</source>
                <volume>17</volume>
                <fpage>211</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18541972</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.neirafresneda.2015.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neira-Fresneda</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Neurodevelopmental disorders associated with abnormal gene dosage: Smith-Magenis and Potocki-Lupski Syndromes.</article-title>
                <source>J Pediatr Genet</source>
                <volume>4</volume>
                <fpage>159</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">27617127</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.park.2002.729">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankiewicz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehoczky</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birren</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs.</article-title>
                <source>Genome Res</source>
                <volume>12</volume>
                <fpage>729</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">11997339</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.potocki.2007.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treadwell-Deering</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>CMB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eifert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaze</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krull</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendoza-Londono</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins-Furman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenberger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Withers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yatsenko</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankiewicz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism Phenotype.</article-title>
                <source>Am J Hum Genet</source>
                <volume>80</volume>
                <fpage>633</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">17357070</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.potocki.2000.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>K-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osterholm</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Withers</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summers</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashork</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Molecular mechanism for duplication 17p11.2 - the homologous recombination reciprocal of the Smith-Magenis microdeletion.</article-title>
                <source>Nat Genet</source>
                <volume>24</volume>
                <fpage>84</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10615134</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.sanchezvalle.2011.363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanchez-Valle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierpont</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The severe end of the spectrum. Hypoplastic left heart in Potocki-Lupski syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>363</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21271655</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.soleralfonso.2011.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soler-Alfonso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motil</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turk</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins-Furman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraley</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Potocki-Lupski syndrome: A microduplication syndrome associated with oropharyngeal dysphagia and failure to thrive.</article-title>
                <source>J Pediatr</source>
                <volume>158</volume>
                <fpage>655</fpage>
                <lpage>9.e2</lpage>
                <pub-id pub-id-type="pmid">21168152</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.stankiewicz.2010.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stankiewicz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Structural variation in the human genome and its role in disease.</article-title>
                <source>Ann Rev Med</source>
                <volume>61</volume>
                <fpage>437</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">20059347</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.treadwelldeering.2010.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Treadwell-Deering</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cognitive and behavioral characterization of the Potocki-Lupski syndrome (duplication 17p11.2).</article-title>
                <source>J Dev Behav Pediatr</source>
                <volume>31</volume>
                <fpage>137</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">20110824</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.walz.2006.3035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paylor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).</article-title>
                <source>J Clin Invest</source>
                <volume>116</volume>
                <fpage>3035</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17024248</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.walz.2004.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaasik</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paylor</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>367</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">14709593</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.yuan.2015.691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burglen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chantot-Bastaraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelowani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>CMB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magoulas</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Nonrecurrent 17p11.2p12 rearrangement events that result in two concomitant genomic disorders: the PMP22-RAI1 contiguous gene duplication syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>97</volume>
                <fpage>691</fpage>
                <lpage>707</lpage>
                <pub-id pub-id-type="pmid">26544804</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.yusupov.2011.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yusupov</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacro</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandstrom</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligon</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Potocki-Lupski syndrome: An inherited dup(17)(p11.2p11.2) with hypoplastic left heart.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>155A</volume>
                <fpage>367</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">21271656</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.zhang.2009.849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khajavi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towne</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>J.R.</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans.</article-title>
                <source>Nat Genet</source>
                <volume>41</volume>
                <fpage>849</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">19543269</pub-id>
              </element-citation>
            </ref>
            <ref id="potocki-lupski.REF.zhang.2010.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Valle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins-Furman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spence</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brasington</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Withers</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.</article-title>
                <source>Am J Hum Genet</source>
                <volume>86</volume>
                <fpage>462</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20188345</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="potocki-lupski.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="potocki-lupski.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>24 August 2017 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>10 October 2016 (jn) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="potocki-lupski.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Individuals with Potocki-Lupski syndrome. The facial features are not strikingly dysmorphic though common findings include micrognathia in early childhood, and down-slanting palpebral fissures. A. Female age three years ten monthsB. Male age five yearsC. Male age three yearsD. Female age eight yearsE. Female age 12 yearsF. Male age 29 years</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="potocki-lupski-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
